Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Dec 27;102(52):19168-73.
doi: 10.1073/pnas.0507480102. Epub 2005 Dec 15.

Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior

Affiliations

Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior

Benjamin Boutrel et al. Proc Natl Acad Sci U S A. .

Abstract

Hypocretin-1 and -2 (Hcrt-1 and Hcrt-2), also referred to as orexin-A and -B, are neuropeptides synthesized by a few thousand neurons in the lateral hypothalamus. Hypocretin-containing neurons project throughout the brain, with a prominent input to basal forebrain structures involved in motivation, reward, and stress. However, the role of hypocretins in addiction-related behaviors remains largely unexplored. Here we show that intracerebroventricular infusions of Hcrt-1 lead to a dose-related reinstatement of cocaine seeking without altering cocaine intake in rats. Hcrt-1 also dramatically elevates intracranial self-stimulation thresholds, indicating that, unlike treatments with reinforcing properties such as cocaine, Hcrt-1 negatively regulates the activity of brain reward circuitries. Hypocretin-induced reinstatement of cocaine seeking was prevented by blockade of noradrenergic and corticotropin-releasing factor systems, suggesting that Hcrt-1 reinstated drug seeking through induction of a stress-like state. Consistent with this interpretation, the selective Hcrt-1 receptor antagonist SB-334867 blocked footshock-induced reinstatement of previously extinguished cocaine-seeking behavior. These findings reveal a previously unidentified role for hypocretins in driving drug seeking through activation of stress pathways in the brain.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Icv infusions of Hcrt-1 reinstate previously extinguished rewarding behaviors. (A-C) Hcrt-1 dose-dependently reinstates cocaine-seeking behavior. Data are expressed as mean (±SEM) number of active or inactive lever responses during different phases of the experiment (n = 7 in each group), during extinction and after i.c.v. Hcrt-1 infusion (reinstatement). The dose-response effect of Hcrt-1 on relapse to cocaine seeking was determined by using a linear regression (P < 0.05). Hcrt-1 infusion into the lateral ventricle also reinstated previously extinguished food-seeking behavior. (D) Mean (±SEM) responses on the active lever in food-trained rats (n = 6) during different phases of the experiment, after a saline infusion before the last extinction session (extinction), and after i.c.v. infusion of Hcrt-1 (1.5 nmol) (reinstatement). (E) Mean (±SEM) responses on the active/inactive levers in food-trained rats (n = 4) for which pressing the active lever was previously paired with the delivery of food pellets. (F) Mean (±SEM) responses on both levers in non-food-trained rats for which pressing the active lever was not previously paired with the delivery of food pellets (n = 5). #, Significant difference (P < 0.05) between Hcrt-1 doses (0.3 vs. 1.5 nmol); $, significant difference (P < 0.05) between food-paired and non-food-paired lever; asterisks, significant differences (*, P < 0.05; **, P < 0.01) between experimental phases (extinction and reinstatement). See Statistical Analyses.
Fig. 2.
Fig. 2.
Elevated ICSS reward thresholds in rats (n = 9) measured up to 48 h after Hcrt-1 administration into the lateral ventricle. *, statistically significant differences (P < 0.05) compared with Pre thresholds (baseline); #, statistically significant differences (P < 0.05) compared with thresholds in saline-treated rats (n = 5) at the same time points, as determined by planned comparisons among means after statistically significant main effect in the ANOVA. See Statistical Analyses.
Fig. 3.
Fig. 3.
Noradrenergic and CRF systems regulate Hcrt-1-induced reinstatement of cocaine seeking. Data are expressed as mean (±SEM) number of active or inactive lever responses during different phases of the experiment, during extinction (Ext), and after i.c.v. Hcrt-1 infusion (reinstatement, Rein). (A) In absence of pretreatment, Hcrt-1 (n = 8; 1.5 nmol, i.c.v.) induced a robust reinstatement of lever pressing (P < 0.05). Pretreatment with the α2 agonist clonidine (Clon; n = 8; 20 μg/kg, i.p.) (B) or the CRF1/CRF2 antagonist d-Phe-CRF12-41 (n = 10; 1.3 nmol, i.c.v.) (C) attenuated the effect of Hcrt-1 (1.5 nmol, i.c.v.) on reinstatement (P < 0.05), but responding on the previously cocaine-paired active lever remained significantly increased compared with extinction responses (P < 0.05). (D) Coadministration of clonidine (20 μg/kg, i.p.) and d-Phe-CRF12-41(1.3 nmol, i.c.v.) completely blocked the Hcrt-induced reinstatement of cocaine seeking (n = 7, P < 0.05). #, significant difference (P < 0.05) compared with the Hcrt-1; *, statistically significant differences (P < 0.05) between experimental phases (extinction and reinstatement). See Statistical Analyses.
Fig. 4.
Fig. 4.
Involvement of the Hcrt system in stress-induced relapse of cocaine seeking. Footshock induced a significant increase in the number of responses on the previously cocaine-paired active lever in vehicle-treated rats (n = 14) (A), whereas pretreatment with the Hcrt-1 receptor antagonist SB-334867 (15 mg/kg i.p., n = 8; 30 mg/kg i.p., n = 5) did not induce a significant increase in responding on the active lever (B and C). Data are expressed as mean (±SEM) number of active or inactive lever responses during extinction and footshock-induced reinstatement for cocaine seeking. *, Significant difference (P < 0.05) between experimental phases (extinction and footshock); #, significant difference (P < 0.05) compared with vehicle-treated rats. See Statistical Analyses.

References

    1. O'Brien, C. P. (1997) Science 278, 66-70. - PubMed
    1. de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L., Gautvik, V. T., Bartlett, F. S., et al. (1998) Proc. Natl. Acad. Sci. USA 95, 322-327. - PMC - PubMed
    1. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) Cell 92, 573-585. - PubMed
    1. Willie, J. T., Chemelli, R. M., Sinton, C. M. & Yanagisawa, M. (2001) Annu. Rev. Neurosci. 24, 429-458. - PubMed
    1. Taheri, S., Zeitzer, J. M. & Mignot, E. (2002) Annu. Rev. Neurosci. 25, 283-313. - PubMed

Publication types

MeSH terms

LinkOut - more resources